Shares of GSK PLC GSK inched down 0.77% to £13.50 Thursday, on what proved to be an all-around positive trading session for ...

Read about vaccine sales, Akums and more in the latest Market Talks covering Health Care.

Barré for every million doses given.

GSK Plc is in talks to buy biotech company IDRx, people with knowledge of the matter said, a deal that would see the British ...

--Pharmaceutical giant GSK PLC is in talks to buy U.S. privately owned biotech company IDRx, which is developing a treatment for rare gastrointestinal tumors, for up to $1 billion, the Financial Times ...

The move will place students in good stead to take up skilled roles in biopharma manufacturing. Read more at straitstimes.com ...

Ken Hall looks at two big investment risks that are keeping him up at night as we enter 2025 with the UK stock market ...

The list prices of the top 25 drugs with the highest Medicare Part D spend that are not subject to drug price negotiations ...

The FDA is adding a warning about Guillain-Barré syndrome to the respiratory syncytial virus vaccines manufactured by GSK and ...

In July 2024, Moderna was awarded $176 million from the US government to advance the development of its mRNA H5N1 (bird flu) ...

The newly launched biotech is equipped with rights to a trio of weight loss medicines licensed from China-based Sciwind ...

Candel Therapeutics’ CEO had to prioritize a phase 3 program amid layoffs and cuts, and an end-of-year clinical success was the redemption he was looking for.